Hans Bisgaard
Pioneering researcher in childhood asthma. He was born in Aarhus, Denmark, on Jan 24, 1955 and died in Copenhagen, Denmark, on Sept 8, 2022 aged 67 years.
Stay updated with breaking news from View Large. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pioneering researcher in childhood asthma. He was born in Aarhus, Denmark, on Jan 24, 1955 and died in Copenhagen, Denmark, on Sept 8, 2022 aged 67 years.
On Sept 28, 2022, the UK Health Security Agency (UKHSA) issued a press release calling on all those eligible for influenza and COVID-19 booster vaccinations to ensure that they take up the offer. “Flu and COVID-19 are unpredictable but there are strong indications we could be facing the threat of widely circulating flu, lower levels of natural immunity due to less exposure over the last three winters and an increase in COVID-19 circulating with lots of variants that can evade the immune response”, stated Susan Hopkins, Chief Medical Advisor at UKHSA.
The book COVID and Custom in Rural South Africa: Culture, Healthcare and the State was born out of research commissioned by a government development agency in the Eastern Cape province of South Africa, during the first and second waves of the COVID-19 pandemic. It tells the story of how marginalised communities in the rural periphery of South Africa experienced the constraints placed on their funerals and customary practices during one of the world's longest and most restrictive lockdowns.
On Sept 29, 2022, the Africa Union Commission announced the New Public Health Order, calling on governments, multilateral organisations, philanthropic groups, the private sector, and civil society to support its full implementation. The African Commission is the secretariat of the Africa Union—an intergovernmental organisation representing all 55 African states. The New Public Health Order outlines five major health priorities and calls for greater investment in health institutions, health workforce, and medical manufacturing capacity.
The FDA has authorised bivalent booster vaccines containing mRNA for the ancestral SARS-CoV-2 variant as well as B.1.1.529.4 (BA.4) and B.1.1.529.5 (BA.5), the latter being the most prevalent omicron subvariant circulating now.